First human test of Pfizer's new cancer fighter
NCT ID NCT06285097
Summary
This early-stage study tested the safety and initial effectiveness of a new drug called PF-07820435, both alone and combined with an existing immunotherapy (sasanlimab), in people with advanced solid tumors. The trial involved a small group of participants with cancers like lung cancer, melanoma, and others that had spread or returned after prior treatments. The main goals were to find a safe dose and look for early signs that the drug could help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Corewell Health (reference non-engagement letter)
Grand Rapids, Michigan, 49503, United States
-
Florida Cancer Specialists Sarasota Drug Development Unit
Sarasota, Florida, 34232, United States
-
Hospital Oncologico Dr. Isaac Gonzalez-Martinez
Rio Piedras, 00935, Puerto Rico
-
National Cancer Center Hospital East
Kashiwa, Chiba, 277-8577, Japan
-
Pan American Center for Oncology Trials, LLC
Rio Piedras, 00935, Puerto Rico
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
START Midwest
Grand Rapids, Michigan, 49546, United States
-
Sarah Cannon Research Institute - Pharmacy
Nashville, Tennessee, 37203, United States
-
The Cancer Institute Hospital of JFCR
Koto, Tokyo, 135-8550, Japan
-
Tristar Centennial Medical Center
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.